Giapreza - (2.5 mg/mL ; Injection)

Generic Name	Angiotensin II Acetate	Innovator	La Jolla pharma
Dosage	2.5 mg/mL ; Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	Less Than 5
Final Approvals	None	Generic Launches	None
Indication	GIAPREZA is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***** ******	*** / *********	**** **, ****	*******	********* ********	*** ****** **** ****

Chronology Of Events